Valence Labs is a pioneering company at the forefront of AI in drug discovery. They are committed to developing innovative AI technologies that are transforming the way we discover and develop treatments for complex diseases. Their research is driven by optimism, purpose, and a shared vision of a healthier tomorrow. Valence Labs was launched with the goal of harnessing computation to improve human health, hoping to create tangible patient impact.
They have built a reputation for living at the frontier of AI and drug discovery, besting giants in high-profile machine learning competitions. Now, they have joined forces with Recursion to create a semi-autonomous research and productization engine dedicated to advancing the frontier of deep learning in drug discovery. This collaboration presents a generational opportunity to rewrite the rules of therapeutic discovery.